Fig. 2. B. cinerea secretes small RNA effectors through EVs.
a B. cinerea sRNAs were examined in B. cinerea EVs isolated by sucrose gradient fractionation. b B. cinerea sRNAs can be protected from micrococcal nuclease treatment by EVs. F4, B. cinerea EV samples were collected from fraction 4 after sucrose gradient centrifugation. Bc-siR17 and Bc-siR9 were used as negative controls. c The Δbcpls1 strain showed strongly reduced virulence, whereas the Δbctsp3 strain showed similar virulence with the wild-type B05 strain. Both Δbcpls1 and Δbctsp3 complementary strains showed similar virulence with the wild-type B05 strain. d Bc-sRNAs were examined by Real-time PCR in EVs isolated from B05, Δbcpls1, Δbctsp3, Δbcpls1 complementary, and Δbctsp3 complementary strains. The data are presented as mean ± s.d. Similar results were obtained in three biologically independent experiments. e Wild-type B. cinerea EVs partially complement the virulence of B. cinerea Δbcpls1 mutant. Premixing of wild-type B. cinerea EVs from sucrose gradient fraction 4 with Δbcpls1 mutant spores partially complement the weak virulence of Δbcpls1 on Arabidopsis leaves. f Wild-type B. cinerea EVs partially complement the virulence of B. cinerea dcl1dcl2 mutant. Premixing of wild-type B. cinerea EVs from sucrose gradient fraction 4 with dcl1dcl2 mutant spores partially complements the weak virulence of dcl1dcl2 on Arabidopsis leaves. Relative lesion size was determined 2 days after infection. The statistical data in c, e and f are presented as mean ± s.d., n = 10 biological replicates. The statistical analysis was performed using ANOVA Dunnett’s multiple comparisons test. The small open circles represent individual values. The error bars indicate s.d. **P < 0.01, ***P < 0.001. Source data are provided as a Source Data file.